# Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

> **NCT00079391** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 50 (actual)

## Conditions studied

- Hematologic Malignancies
- Bone Marrow Transplant Rejection

## Interventions

- **DEVICE:** allogeneic hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT00079391
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2008-12
- **Final completion:** 2011-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00079391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00079391, "Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00079391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*